Compass Therapeutics (CMPX) Leases: 2023-2025
Historic Leases for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $9.5 million.
- Compass Therapeutics' Leases rose 36.00% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 36.00%. This contributed to the annual value of $6.7 million for FY2024, which is 279.00% up from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Leases is $9.5 million, which was down 3.59% from $9.8 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Leases high stood at $9.8 million for Q2 2025, and its period low was $1.2 million during Q2 2024.
- In the last 3 years, Compass Therapeutics' Leases had a median value of $2.7 million in 2023 and averaged $4.6 million.
- In the last 5 years, Compass Therapeutics' Leases crashed by 51.66% in 2024 and then skyrocketed by 750.30% in 2025.
- Quarterly analysis of 3 years shows Compass Therapeutics' Leases stood at $1.8 million in 2023, then surged by 279.00% to $6.7 million in 2024, then skyrocketed by 36.00% to $9.5 million in 2025.
- Its Leases was $9.5 million in Q3 2025, compared to $9.8 million in Q2 2025 and $6.5 million in Q1 2025.